Stoke Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.12.24	Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday (Benzinga)
04.12.24	Stoke Therapeutics Receives Breakthrough Therapy Designation For Zorevunersen (RTTNews)
28.06.24	A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics (Benzinga)
07.06.24	These Biotech Stocks Hit New Highs, Did You Reap The Rewards? (RTTNews)
06.05.24	Stoke Therapeutics Inc Q1 Loss increases, but beats estimates (RTTNews)
29.04.24	Stoke Therapeutics CFO Stephen Tulipano Resigns; Thomas Leggett Named Replacement (RTTNews)
04.04.24	Assessing Stoke Therapeutics: Insights From 6 Financial Analysts (Benzinga)
26.03.24	What's Going On With Stoke Therapeutics Stock Tuesday? (Benzinga)
26.03.24	MÄRKTE USA/Etwas leichter - Zurückhaltung vor Inflationsdaten (Dow Jones)
26.03.24	MÄRKTE USA/Gut behauptet - Hoffen auf Inflationsdaten (Dow Jones)
26.03.24	MÄRKTE USA/Etwas fester - Hoffen auf Preisdaten (Dow Jones)
26.03.24	MÄRKTE USA/Etwas fester - Hoffen auf Preisdaten (Dow Jones)
26.03.24	Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket (Benzinga)
25.03.24	Stoke Therapeutics Stock Rockets On Phase 1/2a Data: Here's Why (Benzinga)
25.07.23	Stoke Reports Safety And Efficacy Data From Phase 1/2a Studies Of STK-001 In Dravet Syndrome (RTTNews)
08.08.22	Stoke Therapeutics Posts Wider Loss In Q2 (RTTNews)
21.09.21	Stoke Therapeutics: Initial Safety Data From MONARCH Study Highly Encouraging (RTTNews)
01.06.21	Die Expertenmeinungen zur Stoke Therapeutics-Aktie im Mai 2021 (finanzen.net)
31.03.21	So stuften die Analysten die Stoke Therapeutics-Aktie im vergangenen Monat ein (finanzen.net)
31.12.20	Stoke Therapeutics-Aktie: Das sind die Analysten-Einstufungen des vergangenen Monats (finanzen.net)
30.11.20	Analysten sehen bei Stoke Therapeutics-Aktie Potenzial (finanzen.net)
19.11.20	Pre-market Movers In Healthcare Sector: APVO, CORT, TTNP, BLU, MGTX... (RTTNews)
11.11.20	FPRX Takes Flight On FIGHT Data, AGTC To Report XLRP Trial Results, PDSB To Advance COVID-19 Vaccine (RTTNews)
23.03.20	Stoke Therapeutics Reports Full Year 2019 Financial Results and Provides Business Updates (Businesswire)
24.02.20	Stoke Therapeutics to Present at 40th Annual Cowen Health Care Conference (Businesswire)
07.01.20	Stoke Therapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference (Businesswire)
24.12.19	ACST On Watch, ITCI Jumps 250% On Trial Data, CVM Slumps, FDA Nod For AGN (RTTNews)
23.12.19	Stoke Therapeutics Added to NASDAQ Biotechnology Index (Businesswire)
08.12.19	At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK... (RTTNews)
26.11.19	Stoke Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference (Businesswire)
25.11.19	Stoke Therapeutics to Present New Preclinical Data on STK-001 at the American Epilepsy Society Annual Meeting (Businesswire)
12.11.19	Stoke Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update (Businesswire)
05.11.19	Stoke Therapeutics to Present at Upcoming Investor Conferences in November (Businesswire)
30.10.19	Today's Top 5 Gainers In Healthcare Sector (ISEE, CYCN, STOK…) (RTTNews)
16.10.19	Stoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal Officer and Joan Wood as Head of Human Resources (Businesswire)
30.09.19	Stoke Therapeutics to Present at 2019 Cantor Global Healthcare Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Stoke Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten